novo nordisk oral glp-1 strikes $2.1bn obesity biologic deal with Vivtex | News Ro Launches Wegovy® Pill Through

This Joint Undertaking receives support from the European Unions Horizon 2020 research and innovation program and EFPIA and the T1D Exchange, JDRF and Obesity Action Coalition

Daytime Sleepiness: A common complaint from those undergoing GHS treatment is excessive fatigue or sleepiness during the day

Clinical Trial Registry (2025) 12

What makes therapeutic peptides compelling for longevity science is their specificity: unlike small-molecule drugs, which often bind promiscuously to multiple receptor types, peptides tend to interact with highly selective targets, producing narrower and more predictable biological effects [1]

Already Subscribed

2025;43((Suppl